Does Dr. MICHAEL AGNICH have financial conflicts of interest?

Dr. MICHAEL AGNICH (CRNA) has received a total of $583 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $583 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MICHAEL AGNICH?

According to CMS Open Payments data, Dr. MICHAEL AGNICH received funding from PACIRA PHARMACEUTICALS INCORPORATED ($550), HERON THERAPEUTICS ($18), and ACACIA PHARMA ($16).

Does Dr. MICHAEL AGNICH receive research grants or speaking fees?

Dr. MICHAEL AGNICH has received $583 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MICHAEL AGNICH

CRNAReal-Time Hydrated

Specialty: Nurse Anesthetist, Certified Registered

Practice Location: NEW LENOX, IL 60451

NPI Number: 1922010933

LIFETIME INDUSTRY VALUE

$583

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AGNICH is a verified Nurse Anesthetist, Certified Registered practitioner based in NEW LENOX, IL.

Between 2021 and 2025, Dr. AGNICH had an overall industry promotional and research financial footprint of $583 as recorded in the federal CMS Open Payments database.

$583 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGNICH's primary funding source is PACIRA PHARMACEUTICALS INCORPORATED, which accounts for $550 (representing 94.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PACIRA PHARMACEUTICALS INCORPORATED

Rank 1

$550

94.2%

HERON THERAPEUTICS

Rank 2

$18

ACACIA PHARMA

Rank 3

$16

2.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.